Function of the IGF-I receptor in breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 5, Issue 1, 2000, Pages 95-105

  Surmacz, E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antiestrogen; Breast cancer; Estrogen independence; Insulin like growth factor I receptor; IRS 1; Metastasis

Indexed keywords

ESTROGEN; INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN C RECEPTOR;

BREAST CANCER; BREAST TUMOR; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DISEASE COURSE; ENZYME SPECIFICITY; HORMONE RESPONSIVE ELEMENT; HUMAN; HYPERACTIVITY; LIGAND BINDING; METASTASIS; PLEIOTROPY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; PHOSPHOPROTEINS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0033838566     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009523501499     Document Type: Review

References (58)

1. The insulin-like growth factor receptor: Molecular biology, heterogeneity, and regulation
2. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor
3. The IGF-IR receptor in normal and abnormal growth
4. Type I insulin-like growth factor receptor function in breast cancer
5. Survival factors and apoptosis
6. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology
7. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggest structural determinants that define functional specificity
8. Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression
9. Structure and function of the insulin-like growth factor I receptor
10. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor
11. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth
12. The IRS-signalling system: A network of docking proteins that mediate insulin action
13. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling
14. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability
15. What does insulin do to Ras?
16. The IGF-IR in mitogenesis and transformation of mouse embryo fibroblasts: Role of receptor number
17. Molecular markers of IGF-I-mediated mitogenesis
18. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growith factor I receptors
19. Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression
20. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor
21. Insulin-like growth factor I receptor signaling in transformation by src oncogenes
22. Differential roles of ARS-1 and SHC signaling pathways in breast cancer calls
23. Overexpressed IGF-IR induce reorganization of actin cytoskeleton and dephosphorylation of focal adhesion proteins: GAK, Cas, and paxilln
24. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses
25. Overexpression of IRS-1 in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation
26. Transforming potential of the insulin receptor substrate 1 (IRS-1)
27. SHC-alpha5 beta1 integrin interactions regulate breast cancer cell adhesion and motility
28. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion
29. Overexpressed IGF-I receptor reduce estrogen growth requirements, enhance survival and promote cell-cell adhesion in human breast cancer cells
30. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor I, insulin and interleukin-4 in estrogen receptor-positive human breast cancer cells
31. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs
32. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
33. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol
34. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells
35. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro an in vivo
36. Insulin-receptor substrate 1 (IRS-1) is a substrate for a pure antiestrogen ICI 182,780
37. Oestrogen/growth factor cross-talk in breast carcinoma: A specific target for novel antiestrogens
38. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells
39. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated FAS-associated protein tyrosine phosphatase-1 in human breast cancer cells
40. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer
41. IGF-I receptor and cyclin D1 expression influence cellular radiosensitivity and local breast cancer recurrence after lumpectomy and radiation
42. Insulin-like growth factor-I (IGF-I) receptor in breast cancer
43. Type 1 IGF receptor in human breast diseases
44. Sporadic amplification of the insulin-like growth factor I receptor gene in human breast cancer
45. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal
46. Wild type and mutant p53 differentially regulate transcription of insulin-like growth factor I receptor gene
47. Insulin-like growth factor-binding protein 3 and insulin receptor substrate 1 in breast cancer: Correlation with clinical parameters and disease-free survival
48. Immunological studies of type IIGF receptors and insulin receptors: Characterization of hybrid and atypical receptor subtypes
49. The prognostic value of insulin-like growth factor I in breast cancer. Results of a follow-up study on 126 patients
50. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer
51. Insulin-like growth factor I receptors and insulin-like activity in human primary breast cancer
52. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: Correlation with ERB2 and p66 She expression
53. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells
54. Characterization of insulin-like growth factor 1 receptors (IGF-IR) in human breast cancer cell lines
55. Insulin and insulin-like growth factor signaling are defective in MDA-MB-468 human breast cancer cell line
56. The roles of integrins and extracellular matrix proteins in the IGF-IR-stimulated chemotaxis of human breast cancer cells
57. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
58. A 'dominant negative mutant of the insulin-like growth factor receptor inhibits the adhesion, invasion and metastasis of breast cancer